Elicio Therapeutics, Inc. (ELTX)

Profile

Full Name

Elicio Therapeutics, Inc.

Ticker

NASDAQ: ELTX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

February 5, 2021

Indexes

Not included

Website

https://elicio.com

Employees

32

Key Details

Price

$9.98(+1.73%)

Market cap

$159.65M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$4.25(+38.94% YoY)

PE ratio

-

Next earnings date

Aug 13, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $9.98
    ELTX price is $9.98

    30-Day Relative Volume

    0.47
    ELTX 30-day relative volume is 0.47

    Price Performance

    Price Most recent change

    +1.73%
    ELTX price was up +1.73% on Aug 1, 2025

    Price YTD change

    +95.69%
    ELTX price is up +95.69% since January 1st

    Price 1-year change

    +96.46%
    ELTX price is up +96.46% year-on-year

    Price 3-year change

    -6.73%
    ELTX price is down -6.73% over the past 3 years

    Price Range

    Price All-time high

    $263.00
    ELTX price is currently -96.21% below its historical high of $263.00

    Price 3-year low

    $2.96
    ELTX price is currently +237.16% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $159.65M
    ELTX market capitalization is $159.65 million

    Market cap 3-year change

    -
    ELTX market capitalization 3-year change is unknown

    Market cap All-time high

    $162.21M
    ELTX market capitalization is currently -1.58% below its historical high of $162.21 million

    Market cap sector rank

    49.88%
    ELTX market capitalization is higher than 49.88% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +48.47%
    ELTX shares outstanding is up +48.47% year-on-year

    Shares Outstanding 3-Year Change

    -
    ELTX shares outstanding 3-year change is unknown

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.11
    ELTX beta is 0.11

    200-day SMA

    $6.66
    ELTX price is currently +49.94% above its 200-day simple moving average

    50-day SMA

    $8.24
    ELTX price is currently +21.15% above its 50-day simple moving average

    RSI

    70.18
    ELTX 14-day relative strength index is 70.18

    Volume

    0.47
    ELTX 30-day relative volume is 0.47

    ATR

    $0.61
    ELTX average true range is $0.61

    10-day Historical Volatility

    33.22%
    ELTX 10-day historical volatility is 33.22%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    -
    ELTX annual revenue value is unknown

    Revenue Analysts estimate

    -
    ELTX annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -
    ELTX annual revenue 1-year change is unknown

    Revenue Sector rank

    -
    ELTX annual revenue is unknown

    EPS

    EPS

    -$4.25
    ELTX annual earnings per share is -$4.25

    EPS Analysts estimate

    -$2.40
    ELTX annual earnings per share is currently +76.72% higher than the consensus analysts' forecast

    EPS 1-year change

    +38.94%
    ELTX annual earnings per share is up +38.94% year-on-year

    EPS Sector rank

    22.96%
    ELTX annual earnings per share is higher than 22.96% of companies in Healthcare sector

    Profit

    Gross profit

    -
    ELTX annual gross profit value is unknown

    Gross margin

    -
    ELTX annual gross profit margin value is unknown

    Operating profit

    -$44.99M
    ELTX annual operating income is -$44.99 million

    Operating margin

    -
    ELTX annual operating profit margin value is unknown

    Net income

    -$51.90M
    ELTX annual net profit is -$51.90 million

    Net margin

    -
    ELTX annual net profit margin value is unknown

    Expenses

    Total expenses

    $44.99M
    ELTX annual total expenses is $44.99 million

    Operating expenses

    $44.99M
    ELTX annual total operating expenses is $44.99 million

    Cost of goods sold

    -
    ELTX annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $11.33M
    ELTX annual SGA is $11.33 million

    Depreciation and amortization

    $1.18M
    ELTX annual depreciation & amortization is $1.18 million

    Interest expense

    $455.00K
    ELTX annual interest expense is $455.00 thousand

    Income tax

    $0.00
    ELTX annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$51.44M
    ELTX annual earnings before interest & taxes is -$51.44 million

    EBITDA

    -$50.27M
    ELTX annual EBITDA is -$50.27 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $28.18M
    ELTX annual total assets is $28.18 million

    Non current assets

    $7.49M
    ELTX annual long term assets is $7.49 million

    Current assets

    $20.69M
    ELTX annual total current assets is $20.69 million

    Cash and cash equivalents

    $17.62M
    ELTX annual cash & cash equivalents is $17.62 million

    Accounts receivable

    -
    ELTX annual accounts receivable value is unknown

    Inventory

    -
    ELTX annual inventory value is unknown

    Liabilities

    Total liabilities

    $39.49M
    ELTX annual total liabilities is $39.49 million

    Long term liabilities

    $27.97M
    ELTX annual total long term liabilities is $27.97 million

    Current liabilities

    $11.52M
    ELTX annual total current liabilities is $11.52 million

    Accounts payable

    $1.04M
    ELTX annual accounts payable is $1.04 million

    Debt

    Total debt

    $26.04M
    ELTX annual total debt is $26.04 million

    Total debt 1-year change

    +276.46%
    ELTX annual total debt is up +276.46% year-on-year

    Long term debt

    $25.14M
    ELTX annual long term debt is $25.14 million

    Short term debt

    $901.00K
    ELTX annual short term debt is $901.00 thousand

    Equity & Capital

    Shareholders equity

    -$11.31M
    ELTX annual stockholders equity is -$11.31 million

    Book value

    -$11.31M
    ELTX annual book value is -$11.31 million

    Retained earnings

    -$194.10M
    ELTX annual retained earnings is -$194.10 million

    Working capital

    $9.17M
    ELTX annual working capital is $9.17 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$37.07M
    ELTX annual cash flow from operations is -$37.07 million

    Cash from operations 1-year change

    -13.38%
    ELTX annual cash flow from operations is down -13.38% year-on-year

    Cash from investing

    -$84.00K
    ELTX annual cash flow from investing activities is -$84.00 thousand

    Cash from investing 1-year change

    -162.5%
    ELTX annual cash flow from investing activities is down -162.5% year-on-year

    Cash from financing

    $42.32M
    ELTX annual cash flow from financing activities is $42.32 million

    Cash from financing 1-year change

    +9.6%
    ELTX annual cash flow from financing activities is up +9.6% year-on-year

    CAPEX

    CAPEX

    -
    ELTX annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    ELTX annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$37.16M
    ELTX annual free cash flow is -$37.16 million

    Free cash flow 1-year change

    -13.42%
    ELTX annual free cash flow is down -13.42% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    ELTX annual gross profit margin value is unknown

    Operating margin

    -
    ELTX annual operating profit margin value is unknown

    Net margin

    -
    ELTX annual net profit margin value is unknown

    ROA & ROE

    ROA

    -184.18%
    ELTX annual return on assets is -184.18%

    ROE

    458.79%
    ELTX annual return on equity is 458.79%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ELTX price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ELTX price to earnings ratio is unknown

    PB Ratio

    PB ratio

    17.93
    ELTX price to book ratio is 17.93

    PB ratio Sector rank

    94.52%
    ELTX price to book ratio is higher than 94.52% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    ELTX price to sales ratio value is unknown

    PS ratio Sector rank

    -
    ELTX price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $147.09M
    ELTX enterprise value is $147.09 million

    Enterprise value Sector rank

    49.62%
    ELTX enterprise value is higher than 49.62% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -2.97
    ELTX EV/EBITDA is -2.97

    EV/EBITDA Sector rank

    32.63%
    ELTX EV/EBITDA is higher than 32.63% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.80
    ELTX annual current ratio is 1.80

    Quick ratio

    -
    ELTX annual quick ratio value is unknown

    Leverage

    Debt to equity

    -2.30
    ELTX annual debt to equity ratio is -2.30

    Interest coverage ratio

    -113.06
    ELTX annual interest coverage ratio is -113.06

    Risk & Stability

    Piotroski F-Score

    -
    ELTX piotroski f-score value is unknown

    Altman Z-Score

    -
    ELTX altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    Jul 17, 25 HC Wainwright & Co.
    Buy
    Apr 2, 25 HC Wainwright & Co.
    Buy
    Oct 31, 24 Jones Trading
    Buy
    Aug 23, 24 HC Wainwright & Co.
    Buy
    Jun 6, 24 HC Wainwright & Co.
    Buy
    May 22, 24 HC Wainwright & Co.
    Buy
    May 1, 24 HC Wainwright & Co.
    Buy
    Apr 1, 24 Oppenheimer
    Perform
    Jan 17, 24 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with ELTX included

    Growing Shares Outstanding
    US stocks
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Elicio Therapeutics, Inc.?
    • Does Elicio Therapeutics, Inc. pay dividends?
    • What sector is Elicio Therapeutics, Inc. in?
    • What industry is Elicio Therapeutics, Inc. in?
    • What country is Elicio Therapeutics, Inc. based in?
    • When did Elicio Therapeutics, Inc. go public?
    • Is Elicio Therapeutics, Inc. in the S&P 500?
    • Is Elicio Therapeutics, Inc. in the NASDAQ 100?
    • Is Elicio Therapeutics, Inc. in the Dow Jones?
    • When was Elicio Therapeutics, Inc.'s last earnings report?
    • When does Elicio Therapeutics, Inc. report earnings?

    What is the ticker symbol for Elicio Therapeutics, Inc.?

    The ticker symbol for Elicio Therapeutics, Inc. is NASDAQ:ELTX

    Does Elicio Therapeutics, Inc. pay dividends?

    No, Elicio Therapeutics, Inc. does not pay dividends

    What sector is Elicio Therapeutics, Inc. in?

    Elicio Therapeutics, Inc. is in the Healthcare sector

    What industry is Elicio Therapeutics, Inc. in?

    Elicio Therapeutics, Inc. is in the Biotechnology industry

    What country is Elicio Therapeutics, Inc. based in?

    Elicio Therapeutics, Inc. is headquartered in United States

    When did Elicio Therapeutics, Inc. go public?

    Elicio Therapeutics, Inc.'s initial public offering (IPO) was on February 5, 2021

    Is Elicio Therapeutics, Inc. in the S&P 500?

    No, Elicio Therapeutics, Inc. is not included in the S&P 500 index

    Is Elicio Therapeutics, Inc. in the NASDAQ 100?

    No, Elicio Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Elicio Therapeutics, Inc. in the Dow Jones?

    No, Elicio Therapeutics, Inc. is not included in the Dow Jones index

    When was Elicio Therapeutics, Inc.'s last earnings report?

    Elicio Therapeutics, Inc.'s most recent earnings report was on May 13, 2025

    When does Elicio Therapeutics, Inc. report earnings?

    The next expected earnings date for Elicio Therapeutics, Inc. is August 13, 2025
    On this page